Free Trial

Sensei Biotherapeutics (SNSE) Insider Trading & Ownership

Sensei Biotherapeutics logo
$0.45 +0.02 (+4.63%)
(As of 12/20/2024 05:31 PM ET)

Sensei Biotherapeutics (NASDAQ:SNSE) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
22.00%
Number Of
Insiders Buying
(Last 3 Years)
4
Amount Of
Insider Buying
(Last 3 Years)
$1.88 M
Number Of
Insiders Selling
(Last 3 Years)
1
Amount Of
Insider Selling
(Last 3 Years)
$5.44 M
Get SNSE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Sensei Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SNSE Insider Buying and Selling by Quarter

Sensei Biotherapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/11/2023John CelebiCEOBuy500$0.85$425.00  
6/1/2023Apeiron Investment Group Ltd.Major ShareholderSell3,441,661$1.58$5,437,824.38  
2/23/2023Apeiron Investment Group Ltd.Major ShareholderBuy2,200$1.61$3,542.00  
3/2/2022James PeyerDirectorBuy1,203$3.20$3,849.60  
3/1/2022Cambrian Biopharma IncMajor ShareholderBuy2,458$3.60$8,848.80  
2/28/2022James PeyerDirectorBuy42$3.60$151.20  
2/24/2022James PeyerDirectorBuy15,000$3.63$54,450.00  
2/23/2022Cambrian Biopharma IncMajor ShareholderBuy2,500$3.80$9,500.00  
2/18/2022Cambrian Biopharma IncMajor ShareholderBuy15,000$3.97$59,550.00  
2/17/2022James PeyerDirectorBuy4,949$4.17$20,637.33  
2/16/2022Cambrian Biopharma IncMajor ShareholderBuy2,551$4.25$10,841.75  
2/14/2022Cambrian Biopharma IncMajor ShareholderBuy10,000$4.18$41,800.00  
2/11/2022Cambrian Biopharma IncMajor ShareholderBuy12,500$4.40$55,000.00  
2/10/2022James PeyerDirectorBuy5,000$4.58$22,900.00  
2/8/2022Cambrian Biopharma IncMajor ShareholderBuy10,000$4.33$43,300.00  
2/4/2022James PeyerDirectorBuy2,500$4.45$11,125.00  
2/3/2022Cambrian Biopharma IncMajor ShareholderBuy17,500$4.65$81,375.00  
1/28/2022James PeyerDirectorBuy8,900$4.22$37,558.00  
1/27/2022Cambrian Biopharma IncMajor ShareholderBuy6,100$4.31$26,291.00  
1/26/2022James PeyerDirectorBuy29,900$4.62$138,138.00  
1/25/2022Cambrian Biopharma IncMajor ShareholderBuy20,100$4.86$97,686.00  
1/24/2022James PeyerDirectorBuy22,707$4.69$106,495.83  
1/21/2022Cambrian Biopharma IncMajor ShareholderBuy24,703$4.94$122,032.82  
1/20/2022James PeyerDirectorBuy20,000$5.17$103,400.00  
1/19/2022Cambrian Biopharma IncMajor ShareholderBuy10,244$4.97$50,912.68  
1/18/2022James PeyerDirectorBuy10,000$5.08$50,800.00  
1/14/2022Cambrian Biopharma IncMajor ShareholderBuy6,219$4.99$31,032.81  
1/13/2022James PeyerDirectorBuy19,953$5.13$102,358.89  
1/12/2022Cambrian Biopharma IncMajor ShareholderBuy9,202$5.22$48,034.44  
1/11/2022James PeyerDirectorBuy10,845$5.18$56,177.10  
12/29/2021Cambrian Biopharma IncMajor ShareholderBuy69,000$4.98$343,620.00  
12/28/2021James PeyerDirectorBuy11,288$5.28$59,600.64  
12/27/2021Cambrian Biopharma IncMajor ShareholderBuy3,712$5.30$19,673.60  
12/23/2021James PeyerDirectorBuy11,000$5.27$57,970.00  
(Data available from 1/1/2013 forward)

SNSE Insider Trading Activity - Frequently Asked Questions

The list of insiders at Sensei Biotherapeutics includes Apeiron Investment Group Ltd., Cambrian Biopharma Inc, James Peyer, and John Celebi. Learn more on insiders at SNSE.

22.00% of Sensei Biotherapeutics stock is owned by insiders. Learn more on SNSE's insider holdings.

The following insiders have purchased SNSE shares in the last 24 months: Apeiron Investment Group Ltd. ($3,542.00), and John Celebi ($425.00).

Insiders have purchased a total of 2,700 SNSE shares in the last 24 months for a total of $3,967.00 bought.

The following insider sold SNSE shares in the last 24 months: Apeiron Investment Group Ltd. ($5,437,824.38).

Insiders have sold a total of 3,441,661 Sensei Biotherapeutics shares in the last 24 months for a total of $5,437,824.38 sold.

Sensei Biotherapeutics Key Executives

  • Mr. John K. Celebi M.B.A. (Age 52)
    President, CEO & Director
    Compensation: $882.28k
  • Dr. Edward Van der Horst Ph.D. (Age 50)
    Chief Scientific Officer
    Compensation: $630.81k
  • Ms. Lora Pike
    Vice President of Investor Relations & Communications
  • Mr. Christopher W. Gerry J.D.
    Senior VP, General Counsel & Secretary
  • Ms. Stephanie Krebs M.B.A. (Age 46)
    M.S., Chief Business Officer
  • Dr. Aaron Weitzman FACP
    M.D., Ph.D., Chief Medical Officer


This page (NASDAQ:SNSE) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners